A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax in Subjects with Benign Masseteric Hypertrophy
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax in Subjects with Benign Masseteric Hypertrophy
NCT04443244
Hugel
19 February 2024
Congrats! You have your own personal workspace now.